APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Herpersvirus 5 (HHV-5) Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Herpersvirus 5 (HHV-5) Drug Market Analysis and Forecast 2026-2032

Report ID 173999810222 December 2025192 pages

Choose your research edition.

Industry ResearchHuman Herpersvirus 5 (HHV-5) Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Herpersvirus 5 (HHV-5) Drug Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Human Herpersvirus 5 (HHV-5) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Herpersvirus 5 (HHV-5) Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Herpersvirus 5 (HHV-5) Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Herpersvirus 5 (HHV-5) Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Herpersvirus 5 (HHV-5) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Herpersvirus 5 (HHV-5) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Herpersvirus 5 (HHV-5) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Herpersvirus 5 (HHV-5) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Herpersvirus 5 (HHV-5) Drug include Chongqing Fu'an Pharmaceutical, Yangtze River Pharmaceutical, Wuhan Hualong, Sichuan Cologne Pharmaceutical, Shandong Luo Xin Pharmaceutical, Roche, Qianjiang Pharmaceuticals, GlaxoSmithKline and Upright and clear, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Herpersvirus 5 (HHV-5) Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Herpersvirus 5 (HHV-5) Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Human Herpersvirus 5 (HHV-5) Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Herpersvirus 5 (HHV-5) Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Herpersvirus 5 (HHV-5) Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Herpersvirus 5 (HHV-5) Drug sales, projected growth trends, production technology, application and end-user industry.

Human Herpersvirus 5 (HHV-5) Drug Segment by Company

Chongqing Fu'an Pharmaceutical

Yangtze River Pharmaceutical

Wuhan Hualong

Sichuan Cologne Pharmaceutical

Shandong Luo Xin Pharmaceutical

Roche

Qianjiang Pharmaceuticals

GlaxoSmithKline

Upright and clear

On the drug new Asia

Livzon Pharmaceuticals

Hubei Branch benefits medicine

Haikou Kellett

Chongqing Winbond (acquisition of Sichuan Mingxin)

Human Herpersvirus 5 (HHV-5) Drug Segment by Type

Valerian Gilivir Drugs

Foscarnet Sodium Drugs

Ganciclovir

Valacyclovir Drugs

Acyclovir Drugs

Human Herpersvirus 5 (HHV-5) Drug Segment by Application

Organ Transplant Crowd

Immunodeficiency Crowd

CMV Herpes Crowd

Human Herpersvirus 5 (HHV-5) Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Herpersvirus 5 (HHV-5) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Herpersvirus 5 (HHV-5) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Herpersvirus 5 (HHV-5) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Herpersvirus 5 (HHV-5) Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Herpersvirus 5 (HHV-5) Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Herpersvirus 5 (HHV-5) Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Valerian Gilivir Drugs Major Manufacturers Table 3. Foscarnet Sodium Drugs Major Manufacturers Table 4. Ganciclovir Major Manufacturers Table 5. Valacyclovir Drugs Major Manufacturers Table 6. Acyclovir Drugs Major Manufacturers Table 7. Global Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Organ Transplant Crowd Major Manufacturers Table 9. Immunodeficiency Crowd Major Manufacturers Table 10. CMV Herpes Crowd Major Manufacturers Table 11. Human Herpersvirus 5 (HHV-5) Drug Industry Trends Table 12. Human Herpersvirus 5 (HHV-5) Drug Industry Drivers Table 13. Human Herpersvirus 5 (HHV-5) Drug Industry Opportunities and Challenges Table 14. Human Herpersvirus 5 (HHV-5) Drug Industry Restraints Table 15. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region (2021-2026) Table 19. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region (2027-2032) Table 20. Global Human Herpersvirus 5 (HHV-5) Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2021-2026) & (k units) Table 22. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2027-2032) & (k units) Table 23. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2021-2026) Table 24. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2027-2032) Table 25. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Human Herpersvirus 5 (HHV-5) Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Human Herpersvirus 5 (HHV-5) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Human Herpersvirus 5 (HHV-5) Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers, Product Type & Application Table 33. Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Human Herpersvirus 5 (HHV-5) Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type (2021-2026) Table 40. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type (2027-2032) Table 41. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 43. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2027-2032) & (k units) Table 44. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2021-2026) Table 45. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2027-2032) Table 46. Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2021-2026) & (US$/unit) Table 47. Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2027-2032) & (US$/unit) Table 48. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application (2021-2026) Table 52. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application (2027-2032) Table 53. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 55. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2027-2032) & (k units) Table 56. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2021-2026) Table 57. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2027-2032) Table 58. Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2027-2032) & (US$/unit) Table 60. Chongqing Fu'an Pharmaceutical Company Information Table 61. Chongqing Fu'an Pharmaceutical Business Overview Table 62. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 64. Chongqing Fu'an Pharmaceutical Recent Development Table 65. Yangtze River Pharmaceutical Company Information Table 66. Yangtze River Pharmaceutical Business Overview Table 67. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 69. Yangtze River Pharmaceutical Recent Development Table 70. Wuhan Hualong Company Information Table 71. Wuhan Hualong Business Overview Table 72. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 74. Wuhan Hualong Recent Development Table 75. Sichuan Cologne Pharmaceutical Company Information Table 76. Sichuan Cologne Pharmaceutical Business Overview Table 77. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 79. Sichuan Cologne Pharmaceutical Recent Development Table 80. Shandong Luo Xin Pharmaceutical Company Information Table 81. Shandong Luo Xin Pharmaceutical Business Overview Table 82. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 84. Shandong Luo Xin Pharmaceutical Recent Development Table 85. Roche Company Information Table 86. Roche Business Overview Table 87. Roche Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Roche Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 89. Roche Recent Development Table 90. Qianjiang Pharmaceuticals Company Information Table 91. Qianjiang Pharmaceuticals Business Overview Table 92. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 94. Qianjiang Pharmaceuticals Recent Development Table 95. GlaxoSmithKline Company Information Table 96. GlaxoSmithKline Business Overview Table 97. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 99. GlaxoSmithKline Recent Development Table 100. Upright and clear Company Information Table 101. Upright and clear Business Overview Table 102. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 104. Upright and clear Recent Development Table 105. On the drug new Asia Company Information Table 106. On the drug new Asia Business Overview Table 107. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 109. On the drug new Asia Recent Development Table 110. Livzon Pharmaceuticals Company Information Table 111. Livzon Pharmaceuticals Business Overview Table 112. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 114. Livzon Pharmaceuticals Recent Development Table 115. Hubei Branch benefits medicine Company Information Table 116. Hubei Branch benefits medicine Business Overview Table 117. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 119. Hubei Branch benefits medicine Recent Development Table 120. Haikou Kellett Company Information Table 121. Haikou Kellett Business Overview Table 122. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 124. Haikou Kellett Recent Development Table 125. Chongqing Winbond (acquisition of Sichuan Mingxin) Company Information Table 126. Chongqing Winbond (acquisition of Sichuan Mingxin) Business Overview Table 127. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 129. Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Development Table 130. North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 133. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2027-2032) & (k units) Table 134. North America Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 135. North America Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 136. North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2026) & (US$ Million) Table 137. North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2027-2032) & (US$ Million) Table 138. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 139. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2027-2032) & (k units) Table 140. North America Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 141. North America Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 142. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 146. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 147. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2027-2032) & (k units) Table 148. North America Human Herpersvirus 5 (HHV-5) Drug Sales Price by Country (2021-2026) & (US$/unit) Table 149. North America Human Herpersvirus 5 (HHV-5) Drug Sales Price by Country (2027-2032) & (US$/unit) Table 150. United States Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 151. Canada Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 152. Mexico Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 153. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2026) & (US$ Million) Table 154. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2027-2032) & (US$ Million) Table 155. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 156. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2027-2032) & (k units) Table 157. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 158. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 159. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2026) & (US$ Million) Table 160. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2027-2032) & (US$ Million) Table 161. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 162. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2027-2032) & (k units) Table 163. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 164. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 165. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 169. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 170. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2027-2032) & (k units) Table 171. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Price by Country (2021-2026) & (US$/unit) Table 172. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Price by Country (2027-2032) & (US$/unit) Table 173. Germany Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 174. France Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 175. U.K. Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 176. Italy Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 177. Russia Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 178. Spain Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 179. Netherlands Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 180. Switzerland Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 181. Sweden Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 182. Poland Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 183. China Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2026) & (US$ Million) Table 184. China Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2027-2032) & (US$ Million) Table 185. China Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 186. China Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2027-2032) & (k units) Table 187. China Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 188. China Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 189. China Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2026) & (US$ Million) Table 190. China Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2027-2032) & (US$ Million) Table 191. China Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 192. China Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2027-2032) & (k units) Table 193. China Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 194. China Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 195. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2026) & (US$ Million) Table 196. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2027-2032) & (US$ Million) Table 197. Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 198. Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2027-2032) & (k units) Table 199. Asia Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 200. Asia Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 201. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2026) & (US$ Million) Table 202. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2027-2032) & (US$ Million) Table 203. Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 204. Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2027-2032) & (k units) Table 205. Asia Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 206. Asia Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 207. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 211. Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 212. Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2027-2032) & (k units) Table 213. Asia Human Herpersvirus 5 (HHV-5) Drug Sales Price by Country (2021-2026) & (US$/unit) Table 214. Asia Human Herpersvirus 5 (HHV-5) Drug Sales Price by Country (2027-2032) & (US$/unit) Table 215. Japan Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 216. South Korea Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 217. India Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 218. Australia Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 219. Taiwan Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 220. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 221. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2026) & (US$ Million) Table 222. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2027-2032) & (US$ Million) Table 223. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 224. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2027-2032) & (k units) Table 225. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 226. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 227. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2026) & (US$ Million) Table 228. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2027-2032) & (US$ Million) Table 229. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 230. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2027-2032) & (k units) Table 231. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 232. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 233. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 234. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 235. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 236. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 237. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 238. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2027-2032) & (k units) Table 239. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales Price by Country (2021-2026) & (US$/unit) Table 240. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales Price by Country (2027-2032) & (US$/unit) Table 241. Brazil Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 242. Argentina Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 243. Chile Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 244. Colombia Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 245. Peru Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 246. Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 247. Israel Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 248. UAE Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 249. Turkey Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 250. Iran Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 251. Egypt Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Table 252. Key Raw Materials Table 253. Raw Materials Key Suppliers Table 254. Human Herpersvirus 5 (HHV-5) Drug Distributors List Table 255. Human Herpersvirus 5 (HHV-5) Drug Customers List Table 256. Research Programs/Design for This Report Table 257. Authors List of This Report Table 258. Secondary Sources Table 259. Primary Sources List of Figures Figure 1. Human Herpersvirus 5 (HHV-5) Drug Image Figure 2. Global Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Herpersvirus 5 (HHV-5) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Valerian Gilivir Drugs Image Figure 5. Foscarnet Sodium Drugs Image Figure 6. Ganciclovir Image Figure 7. Valacyclovir Drugs Image Figure 8. Acyclovir Drugs Image Figure 9. Global Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Human Herpersvirus 5 (HHV-5) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Organ Transplant Crowd Image Figure 12. Immunodeficiency Crowd Image Figure 13. CMV Herpes Crowd Image Figure 14. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Human Herpersvirus 5 (HHV-5) Drug Sales (2021-2032) & (k units) Figure 20. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Human Herpersvirus 5 (HHV-5) Drug Sales YoY (2021-2032) & (k units) Figure 23. Europe Human Herpersvirus 5 (HHV-5) Drug Sales YoY (2021-2032) & (k units) Figure 24. China Human Herpersvirus 5 (HHV-5) Drug Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Human Herpersvirus 5 (HHV-5) Drug Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales YoY (2021-2032) & (k units) Figure 27. Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2021-2032) Figure 36. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2021-2032) Figure 42. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type (2021-2032) Figure 43. North America Human Herpersvirus 5 (HHV-5) Drug Sales Share by Type (2021-2032) Figure 44. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application (2021-2032) Figure 45. North America Human Herpersvirus 5 (HHV-5) Drug Sales Share by Application (2021-2032) Figure 46. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Country (2021-2032) Figure 47. North America Human Herpersvirus 5 (HHV-5) Drug Sales Share by Country (2021-2032) Figure 48. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type (2021-2032) Figure 49. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Share by Type (2021-2032) Figure 50. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application (2021-2032) Figure 51. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Share by Application (2021-2032) Figure 52. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Country (2021-2032) Figure 53. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Share by Country (2021-2032) Figure 54. China Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type (2021-2032) Figure 55. China Human Herpersvirus 5 (HHV-5) Drug Sales Share by Type (2021-2032) Figure 56. China Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application (2021-2032) Figure 57. China Human Herpersvirus 5 (HHV-5) Drug Sales Share by Application (2021-2032) Figure 58. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type (2021-2032) Figure 59. Asia Human Herpersvirus 5 (HHV-5) Drug Sales Share by Type (2021-2032) Figure 60. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application (2021-2032) Figure 61. Asia Human Herpersvirus 5 (HHV-5) Drug Sales Share by Application (2021-2032) Figure 62. Asia Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Country (2021-2032) Figure 63. Asia Human Herpersvirus 5 (HHV-5) Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales Share by Country (2021-2032) Figure 70. Human Herpersvirus 5 (HHV-5) Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Human Herpersvirus 5 (HHV-5) Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Valerian Gilivir Drugs
  • Foscarnet Sodium Drugs
  • Ganciclovir
  • Valacyclovir Drugs
  • Acyclovir Drugs
Applications
  • Organ Transplant Crowd
  • Immunodeficiency Crowd
  • CMV Herpes Crowd
Companies covered
  • Chongqing Fu'an Pharmaceutical
  • Yangtze River Pharmaceutical
  • Wuhan Hualong
  • Sichuan Cologne Pharmaceutical
  • Shandong Luo Xin Pharmaceutical
  • Roche
  • Qianjiang Pharmaceuticals
  • GlaxoSmithKline
  • Upright and clear
  • On the drug new Asia
  • Livzon Pharmaceuticals
  • Hubei Branch benefits medicine
  • Haikou Kellett
  • Chongqing Winbond (acquisition of Sichuan Mingxin)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Herpersvirus 5 (HHV-5) Drug Market by Type
  3. 1.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Valerian Gilivir Drugs
  5. 1.2.3 Foscarnet Sodium Drugs
  6. 1.2.4 Ganciclovir
  7. 1.2.5 Valacyclovir Drugs
  8. 1.2.6 Acyclovir Drugs
  9. 1.3 Human Herpersvirus 5 (HHV-5) Drug Market by Application
  10. 1.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Organ Transplant Crowd
  12. 1.3.3 Immunodeficiency Crowd
  13. 1.3.4 CMV Herpes Crowd
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Human Herpersvirus 5 (HHV-5) Drug Market Dynamics
  1. 2.1 Human Herpersvirus 5 (HHV-5) Drug Industry Trends
  2. 2.2 Human Herpersvirus 5 (HHV-5) Drug Industry Drivers
  3. 2.3 Human Herpersvirus 5 (HHV-5) Drug Industry Opportunities and Challenges
  4. 2.4 Human Herpersvirus 5 (HHV-5) Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Region
  3. 3.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region
  9. 3.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Manufacturers
  2. 4.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Manufacturers
  6. 4.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Herpersvirus 5 (HHV-5) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Herpersvirus 5 (HHV-5) Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers, Product Type & Application
  13. 4.7 Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Herpersvirus 5 (HHV-5) Drug Market CR5 and HHI
  16. 4.8.2 2025 Human Herpersvirus 5 (HHV-5) Drug Tier 1, Tier 2, and Tier 3
5 Human Herpersvirus 5 (HHV-5) Drug Market by Type
  1. 5.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type
  2. 5.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type
  6. 5.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Herpersvirus 5 (HHV-5) Drug Price by Type
6 Human Herpersvirus 5 (HHV-5) Drug Market by Application
  1. 6.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application
  2. 6.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application
  6. 6.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Herpersvirus 5 (HHV-5) Drug Price by Application
7 Company Profiles
  1. 7.1 Chongqing Fu'an Pharmaceutical
  2. 7.1.1 Chongqing Fu'an Pharmaceutical Company Information
  3. 7.1.2 Chongqing Fu'an Pharmaceutical Business Overview
  4. 7.1.3 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  6. 7.1.5 Chongqing Fu'an Pharmaceutical Recent Developments
  7. 7.2 Yangtze River Pharmaceutical
  8. 7.2.1 Yangtze River Pharmaceutical Company Information
  9. 7.2.2 Yangtze River Pharmaceutical Business Overview
  10. 7.2.3 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  12. 7.2.5 Yangtze River Pharmaceutical Recent Developments
  13. 7.3 Wuhan Hualong
  14. 7.3.1 Wuhan Hualong Company Information
  15. 7.3.2 Wuhan Hualong Business Overview
  16. 7.3.3 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  18. 7.3.5 Wuhan Hualong Recent Developments
  19. 7.4 Sichuan Cologne Pharmaceutical
  20. 7.4.1 Sichuan Cologne Pharmaceutical Company Information
  21. 7.4.2 Sichuan Cologne Pharmaceutical Business Overview
  22. 7.4.3 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  24. 7.4.5 Sichuan Cologne Pharmaceutical Recent Developments
  25. 7.5 Shandong Luo Xin Pharmaceutical
  26. 7.5.1 Shandong Luo Xin Pharmaceutical Company Information
  27. 7.5.2 Shandong Luo Xin Pharmaceutical Business Overview
  28. 7.5.3 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  30. 7.5.5 Shandong Luo Xin Pharmaceutical Recent Developments
  31. 7.6 Roche
  32. 7.6.1 Roche Company Information
  33. 7.6.2 Roche Business Overview
  34. 7.6.3 Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Roche Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  36. 7.6.5 Roche Recent Developments
  37. 7.7 Qianjiang Pharmaceuticals
  38. 7.7.1 Qianjiang Pharmaceuticals Company Information
  39. 7.7.2 Qianjiang Pharmaceuticals Business Overview
  40. 7.7.3 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  42. 7.7.5 Qianjiang Pharmaceuticals Recent Developments
  43. 7.8 GlaxoSmithKline
  44. 7.8.1 GlaxoSmithKline Company Information
  45. 7.8.2 GlaxoSmithKline Business Overview
  46. 7.8.3 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  48. 7.8.5 GlaxoSmithKline Recent Developments
  49. 7.9 Upright and clear
  50. 7.9.1 Upright and clear Company Information
  51. 7.9.2 Upright and clear Business Overview
  52. 7.9.3 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  54. 7.9.5 Upright and clear Recent Developments
  55. 7.10 On the drug new Asia
  56. 7.10.1 On the drug new Asia Company Information
  57. 7.10.2 On the drug new Asia Business Overview
  58. 7.10.3 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  60. 7.10.5 On the drug new Asia Recent Developments
  61. 7.11 Livzon Pharmaceuticals
  62. 7.11.1 Livzon Pharmaceuticals Company Information
  63. 7.11.2 Livzon Pharmaceuticals Business Overview
  64. 7.11.3 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  66. 7.11.5 Livzon Pharmaceuticals Recent Developments
  67. 7.12 Hubei Branch benefits medicine
  68. 7.12.1 Hubei Branch benefits medicine Company Information
  69. 7.12.2 Hubei Branch benefits medicine Business Overview
  70. 7.12.3 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  72. 7.12.5 Hubei Branch benefits medicine Recent Developments
  73. 7.13 Haikou Kellett
  74. 7.13.1 Haikou Kellett Company Information
  75. 7.13.2 Haikou Kellett Business Overview
  76. 7.13.3 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  78. 7.13.5 Haikou Kellett Recent Developments
  79. 7.14 Chongqing Winbond (acquisition of Sichuan Mingxin)
  80. 7.14.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Company Information
  81. 7.14.2 Chongqing Winbond (acquisition of Sichuan Mingxin) Business Overview
  82. 7.14.3 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  84. 7.14.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Developments
8 North America
  1. 8.1 North America Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
  2. 8.1.1 North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Human Herpersvirus 5 (HHV-5) Drug Price by Type (2021-2032)
  5. 8.2 North America Human Herpersvirus 5 (HHV-5) Drug Market Size by Application
  6. 8.2.1 North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Human Herpersvirus 5 (HHV-5) Drug Price by Application (2021-2032)
  9. 8.3 North America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
  10. 8.3.1 North America Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Herpersvirus 5 (HHV-5) Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
  2. 9.1.1 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Herpersvirus 5 (HHV-5) Drug Price by Type (2021-2032)
  5. 9.2 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Application
  6. 9.2.1 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Herpersvirus 5 (HHV-5) Drug Price by Application (2021-2032)
  9. 9.3 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
  10. 9.3.1 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Herpersvirus 5 (HHV-5) Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
  2. 10.1.1 China Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2032)
  4. 10.1.3 China Human Herpersvirus 5 (HHV-5) Drug Price by Type (2021-2032)
  5. 10.2 China Human Herpersvirus 5 (HHV-5) Drug Market Size by Application
  6. 10.2.1 China Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2032)
  8. 10.2.3 China Human Herpersvirus 5 (HHV-5) Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
  2. 11.1.1 Asia Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Herpersvirus 5 (HHV-5) Drug Price by Type (2021-2032)
  5. 11.2 Asia Human Herpersvirus 5 (HHV-5) Drug Market Size by Application
  6. 11.2.1 Asia Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Herpersvirus 5 (HHV-5) Drug Price by Application (2021-2032)
  9. 11.3 Asia Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
  10. 11.3.1 Asia Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Herpersvirus 5 (HHV-5) Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
  2. 12.1.1 SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Herpersvirus 5 (HHV-5) Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Human Herpersvirus 5 (HHV-5) Drug Market Size by Application
  6. 12.2.1 SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Herpersvirus 5 (HHV-5) Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
  10. 12.3.1 SAMEA Human Herpersvirus 5 (HHV-5) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Herpersvirus 5 (HHV-5) Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Herpersvirus 5 (HHV-5) Drug Value Chain Analysis
  2. 13.1.1 Human Herpersvirus 5 (HHV-5) Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Herpersvirus 5 (HHV-5) Drug Production Mode & Process
  6. 13.2 Human Herpersvirus 5 (HHV-5) Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Herpersvirus 5 (HHV-5) Drug Distributors
  9. 13.2.3 Human Herpersvirus 5 (HHV-5) Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst